Fellowship in Action: Our First In-House Manufacturing Run

Earlier this year, Vor Bio dosed its first patient with VCAR33ALLO, a transplant donor-derived CAR-T targeting CD33 in AML patients. VCAR33ALLO is manufactured at our in-house facility in Cambridge, MA, and Voracians were directly involved in every part of the process. We spoke with a few of the team members who participated in this momentous […]

Read More… from Fellowship in Action: Our First In-House Manufacturing Run